IL155428A0 - Pharmaceutical dronedarone composition for parenteral administration - Google Patents
Pharmaceutical dronedarone composition for parenteral administrationInfo
- Publication number
- IL155428A0 IL155428A0 IL15542801A IL15542801A IL155428A0 IL 155428 A0 IL155428 A0 IL 155428A0 IL 15542801 A IL15542801 A IL 15542801A IL 15542801 A IL15542801 A IL 15542801A IL 155428 A0 IL155428 A0 IL 155428A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical
- parenteral administration
- dronedarone
- composition
- dronedarone composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0016071A FR2817750B1 (fr) | 2000-12-11 | 2000-12-11 | Composition pharmaceutique de dronedarone pour administration parenterale |
| PCT/FR2001/003903 WO2002047660A1 (fr) | 2000-12-11 | 2001-12-10 | Composition pharmaceutique de dronedarone pour administration parenterale |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL155428A0 true IL155428A0 (en) | 2003-11-23 |
Family
ID=8857483
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15542801A IL155428A0 (en) | 2000-12-11 | 2001-12-10 | Pharmaceutical dronedarone composition for parenteral administration |
| IL155428A IL155428A (en) | 2000-12-11 | 2003-04-14 | Pharmaceutical drondron composition for administration through blood vessels |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL155428A IL155428A (en) | 2000-12-11 | 2003-04-14 | Pharmaceutical drondron composition for administration through blood vessels |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6939865B2 (pt) |
| EP (1) | EP1343473B1 (pt) |
| JP (1) | JP4399161B2 (pt) |
| KR (1) | KR100849758B1 (pt) |
| CN (1) | CN1235566C (pt) |
| AR (1) | AR031649A1 (pt) |
| AT (1) | ATE348599T1 (pt) |
| AU (2) | AU2002217229B2 (pt) |
| BG (1) | BG66187B1 (pt) |
| BR (1) | BR0116060B1 (pt) |
| CA (1) | CA2427375C (pt) |
| CZ (1) | CZ297788B6 (pt) |
| DE (1) | DE60125411T2 (pt) |
| EA (1) | EA005314B1 (pt) |
| FR (1) | FR2817750B1 (pt) |
| HK (1) | HK1055906A1 (pt) |
| HU (1) | HU229372B1 (pt) |
| IL (2) | IL155428A0 (pt) |
| IS (1) | IS2349B (pt) |
| MA (1) | MA26969A1 (pt) |
| ME (2) | ME00083B (pt) |
| MX (1) | MXPA03005221A (pt) |
| NO (1) | NO332294B1 (pt) |
| NZ (1) | NZ525661A (pt) |
| OA (1) | OA12416A (pt) |
| PL (1) | PL199846B1 (pt) |
| RS (1) | RS50348B (pt) |
| SK (1) | SK287115B6 (pt) |
| TW (1) | TWI246926B (pt) |
| WO (1) | WO2002047660A1 (pt) |
| ZA (1) | ZA200303406B (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR059574A1 (es) * | 2006-02-14 | 2008-04-16 | Wyeth Corp | Formulaciones farmaceuticas acuosas de ligandos selectivos er-beta |
| GB0719180D0 (en) | 2007-10-02 | 2007-11-14 | Cambrex Karlskoga Ab | New process |
| FR2930149B1 (fr) * | 2008-04-17 | 2011-02-18 | Sanofi Aventis | Association de dronedarone avec au moins un diuretique, son application en therapeutique |
| KR20100135909A (ko) | 2008-04-17 | 2010-12-27 | 사노피-아벤티스 | 심혈관성 입원 또는 사망을 예방하는데 사용하기 위한 약제의 제조에 있어서의 드로네다론의 용도 |
| EP2116239A1 (en) * | 2008-04-29 | 2009-11-11 | Sanofi-Aventis | Method for managing the risks associated with an increase in serum creatinine during dronedarone treatment |
| FR2959132A1 (fr) * | 2010-04-22 | 2011-10-28 | Sanofi Aventis | Procedes pour l'evaluation et la reduction des risques |
| TWI508726B (zh) | 2009-12-21 | 2015-11-21 | Gilead Sciences Inc | 治療心房纖維性顫動之方法 |
| US20120005128A1 (en) * | 2010-06-29 | 2012-01-05 | Sanofi | Methods for reducing the risk of an adverse dronedarone / calcium channel blockers interaction in a patient suffering from atrial fibrilation |
| US8602215B2 (en) | 2010-06-30 | 2013-12-10 | Sanofi | Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation |
| CN102342907A (zh) | 2010-07-30 | 2012-02-08 | 江苏恒瑞医药股份有限公司 | 决奈达隆固体分散体及其制备方法 |
| KR20120094557A (ko) * | 2011-02-01 | 2012-08-27 | 동아제약주식회사 | 피에이치 비의존적 용출양상을 갖는 부정맥치료제 제제 |
| CN102908307A (zh) * | 2011-08-03 | 2013-02-06 | 天津市嵩锐医药科技有限公司 | 供注射用盐酸决奈达隆药物组合物及其制备方法 |
| WO2014009500A1 (en) * | 2012-07-12 | 2014-01-16 | Sanofi | Anti-tumoral composition comprising the compound 1-(6-{[6-(4-fluorophenyl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}-1,3-benzothiazol-2-yl)-3-(2-morpholin-4-ylethyl)urea |
| TW202227049A (zh) * | 2020-10-20 | 2022-07-16 | 大陸商上海博志研新藥物技術有限公司 | 鹽酸決奈達隆藥物組合物、其製備方法及應用 |
| TW202320751A (zh) * | 2021-08-16 | 2023-06-01 | 大陸商上海博志研新藥物技術有限公司 | 鹽酸決奈達隆注射組合物、其製備方法及應用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4727064A (en) * | 1984-04-25 | 1988-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Pharmaceutical preparations containing cyclodextrin derivatives |
| FR2746013B1 (fr) * | 1996-03-18 | 1998-05-29 | Sanofi Sa | Utilisation de composes antiarythmiques dans la prevention de la mortalite post infarctus |
| JP2004327321A (ja) * | 2003-04-25 | 2004-11-18 | Jst Mfg Co Ltd | コネクタ |
-
2000
- 2000-12-11 FR FR0016071A patent/FR2817750B1/fr not_active Expired - Fee Related
-
2001
- 2001-12-10 CZ CZ20031612A patent/CZ297788B6/cs not_active IP Right Cessation
- 2001-12-10 AT AT01270322T patent/ATE348599T1/de not_active IP Right Cessation
- 2001-12-10 OA OA1200300152A patent/OA12416A/fr unknown
- 2001-12-10 TW TW090130522A patent/TWI246926B/zh not_active IP Right Cessation
- 2001-12-10 AU AU2002217229A patent/AU2002217229B2/en not_active Ceased
- 2001-12-10 EA EA200300406A patent/EA005314B1/ru not_active IP Right Cessation
- 2001-12-10 ME MEP-2008-204A patent/ME00083B/me unknown
- 2001-12-10 CN CNB018203884A patent/CN1235566C/zh not_active Expired - Fee Related
- 2001-12-10 US US10/450,320 patent/US6939865B2/en not_active Expired - Lifetime
- 2001-12-10 IL IL15542801A patent/IL155428A0/xx active IP Right Grant
- 2001-12-10 CA CA2427375A patent/CA2427375C/fr not_active Expired - Fee Related
- 2001-12-10 DE DE60125411T patent/DE60125411T2/de not_active Expired - Lifetime
- 2001-12-10 SK SK726-2003A patent/SK287115B6/sk not_active IP Right Cessation
- 2001-12-10 JP JP2002549234A patent/JP4399161B2/ja not_active Expired - Fee Related
- 2001-12-10 EP EP01270322A patent/EP1343473B1/fr not_active Expired - Lifetime
- 2001-12-10 PL PL362788A patent/PL199846B1/pl unknown
- 2001-12-10 AU AU1722902A patent/AU1722902A/xx active Pending
- 2001-12-10 ME MEP-204/08A patent/MEP20408A/xx unknown
- 2001-12-10 RS YUP-465/03A patent/RS50348B/sr unknown
- 2001-12-10 ZA ZA200303406A patent/ZA200303406B/en unknown
- 2001-12-10 NZ NZ525661A patent/NZ525661A/en not_active IP Right Cessation
- 2001-12-10 MX MXPA03005221A patent/MXPA03005221A/es active IP Right Grant
- 2001-12-10 BR BRPI0116060-5B1A patent/BR0116060B1/pt not_active IP Right Cessation
- 2001-12-10 KR KR1020037007744A patent/KR100849758B1/ko active IP Right Grant
- 2001-12-10 WO PCT/FR2001/003903 patent/WO2002047660A1/fr active IP Right Grant
- 2001-12-10 HU HU0500842A patent/HU229372B1/hu not_active IP Right Cessation
- 2001-12-10 AR ARP010105716A patent/AR031649A1/es not_active Application Discontinuation
-
2003
- 2003-04-14 IL IL155428A patent/IL155428A/en not_active IP Right Cessation
- 2003-04-18 BG BG107748A patent/BG66187B1/bg unknown
- 2003-04-29 NO NO20031958A patent/NO332294B1/no not_active IP Right Cessation
- 2003-04-30 IS IS6801A patent/IS2349B/is unknown
- 2003-06-03 MA MA27190A patent/MA26969A1/fr unknown
- 2003-11-14 HK HK03108327A patent/HK1055906A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG24357A (en) | New Pharmaceutical composition | |
| IL152659A0 (en) | Pharmaceutical composition | |
| HK1075889A1 (en) | Pharmaceutical composition | |
| GB0001621D0 (en) | Pharmaceutical compositions | |
| HUP0204555A3 (en) | Pharmaceutical composition | |
| AU6219601A (en) | Pharmaceutical compositions | |
| GB0009584D0 (en) | Pharmaceutical compositions | |
| HK1055906A1 (en) | Pharmaceutical dronedarone composition for parenteral administration | |
| AU8576801A (en) | Pharmaceutical compositions | |
| AU2002217229A1 (en) | Pharmaceutical dronedarone composition for parenteral administration | |
| IL154238A0 (en) | Pharmaceutical composition | |
| GB0008485D0 (en) | Pharmaceutical compositions | |
| GB0009613D0 (en) | Pharmaceutical compositions | |
| GB0005382D0 (en) | Pharmaceutical composition | |
| GB0002691D0 (en) | Pharmaceutical composition | |
| GB0101094D0 (en) | Pharmaceutical composition | |
| GB0011724D0 (en) | Pharmaceutical composition for anthelmintics | |
| GB0011725D0 (en) | Pharmaceutical composition for anthelmintics | |
| SI1313467T1 (sl) | Nov farmacevtski sestavek za dajanje N-0923 | |
| GB0006301D0 (en) | Pharmaceutical composition | |
| GB0026716D0 (en) | Pharmaceutical composition | |
| GB0019599D0 (en) | Pharmaceutical composition | |
| GB0016684D0 (en) | Pharmaceutical composition | |
| GB0027375D0 (en) | Pharmaceutical composition | |
| HK1105808A1 (en) | Pharmaceutical formulations for parenteral administration comprising epothilone |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |